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Abstract
Purpose Umbilical cord blood (UCB) stored in public
inventories has become an alternative stem cell source for
allogeneic stem cell transplantation. The potential use of
autologous UCB from private banks is a matter of debate.
In the face of the limited resources of public inventories, a
discussion on ‘‘hybrid’’ public and private UCB banking
has evolved. We aimed to explore the attitudes of the
donating parents toward public and private UCB banking.
Study design and methods A standardized, anonymous
questionnaire was sent to the most recent 621 public UCB
donors including items regarding satisfaction with recruit-
ment process, the need for a second consent before release
of the UCB unit for stem cell transplantation, and the
donors’ views on public and private UCB banking. Fur-
thermore, we asked about their views on UCB research.
Results Of the questionnaires, 48% were returned, and
16% were lost due to mail contact. Of our donors, 95%
would donate to the public bank again. As much as 35% of
them were convinced that public banking was useful.
Whereas 27% had never heard about private UCB banking,
34% discussed both options. Nearly 70% of donors opted
for public banking due to altruism and the high costs of
private banking. Of our public UCB donors, 81% stated
that they did not need a re-consent before UCB release for
stem cell transplantation. In case of sample rejection,
53.5% wanted to know details about the particular research
project. A total of 9% would not consent.
Conclusions Almost all donors would choose public
banking again due to altruism and the high costs of private
banking. Shortly after donation, mail contact with former
UCB donors was difficult. This might be a relevant issue in
any sequential hybrid banking.
Keywords Umbilical cord blood  Public banking 
Private banking  Hybrid banking  Attitudes 
Stem cell research
Introduction
Umbilical cord blood (UCB) is an accepted stem cell
source for allogeneic stem cell transplantation in the
treatment of various malignant and non-malignant diseases
in children and adults [1]. Thus, the demand for UCB
transplants is increasing continuously. At present, more
than 2,000 UCB units from both Swiss public banks (Basel
and Geneva) have been registered and distributed by the
Swiss Blood Stem Cell (SBSC) registry. The delivery of
UCB units has steadily increased from 0 in 1997 to 11 in
2007, reflecting the above-mentioned trend (Fig. 1). Since
the costs for sampling, processing and storage are currently
covered by either philanthropic donors or public services,
the resulting limited resources and therewith logistics are
one major reason for a rather low banking rate [2].
On the other hand, private institutions are now available
throughout most industrialized countries and provide their
services to store UCB for a potential later autologous use.
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Advertisement is made for use in tissue regeneration in
conditions such as diabetes and Parkinson’s disease, as
well as for the treatment of malignant hematologic dis-
eases. True clinical applications, however, are still very
speculative [3]. In contrast to public UCB banking, the
costs are solely covered by the parents and therefore the
donor and the family possess the UCB unit.
Currently, about 300,000 UCB units have been stored
and are available for immediate use through the interna-
tional stem cell registries. They provide stem cell trans-
plants with rare HLA alleles and haplotypes that are
scarcely found in bone marrow registries [4]. However, far
more UCB units have been stored in private institutions. Of
about 800,000 UCB units stored in private banks, clinical
application such as autologous transplantations have been
reported only in few cases [5]. Even less information exists
on whether the stored samples meet the generally accepted
quality criteria, or if rare HLA types are also more frequent
in these inventories.
More recently, combined ‘‘hybrid’’ public and private
UCB banking has emerged due to the limited funding for
public UCB banks in most countries. Since resources are
limited to the collection, processing and storage of good
quality UCB units from all delivered infants, it is reason-
able to consider new business models and combined public
and private UCB banking, thus meeting the demands for
UCB stem cells in general [2]. In contrast to public banking
issues [6], parental attitudes to private banking have been
currently not well studied [3]. Additionally, it is not clear
yet which possible model of hybrid banking is best in the
view of the donating parents. It is unclear whether a split
model, as proposed recently by the Virgin Health Bank in
the UK (80% of the initial UCB unit stored in the public
inventory and 20% of it for private use), is better than a
sequential model in which the whole UCB sample is pri-
marily stored in the private inventory, anonymously
registered at the international stem cell registry and
released after repeated parental consent in case of a request
for allogeneic UCB transplantation [7, 8].
Not all collected UCB samples contain sufficient total
nucleated cell (TNC) numbers and are rejected from the
public UCB bank without further processing. As an alter-
native to discarding these units, they could be used for
research purposes if the donating mother gives consent.
Consent policies vary between a single- or a two-step
procedure.
The aim of our study was to evaluate the attitudes of our
former public UCB donors with regard to public and pri-
vate banking, their wishes and fears concerning the release
of UCB units for allogeneic transplantation and their
opinion regarding the release of UCB units with insuffi-
cient TNC for banking for research. We wanted to know if
our UCB donors would opt for single-step consent for
research donation, or if they would prefer a two-step con-
sent procedure in which the donating mother is informed
about the sample rejection, the reason for rejection and
separately asked to donate the already collected UCB
sample for research purposes.
Materials and methods
Study population
The study population comprised parents who donated UCB
after delivery of their baby to our public UCB bank. Donor
selection procedures, and UCB collection and processing
were performed in accordance with the FACT/Netcord
International Standards for Cellular Therapy Product Col-
lection, Processing, and Administration and approved by
the local ethics committee.
Study design and questionnaire
A standardized multiple choice anonymous questionnaire
including 20 items was developed and sent to the most
recent 621 donors of our public UCB bank in Basel. The
home address given at the time of delivery was used to
contact the donating mothers.
They were asked to give general information on the
infants’ health status, month and year of birth of their last
baby and their country of origin. The questionnaire con-
tained items on the satisfaction with our procedures of
patient information, informed consent and handling during
and after delivery. Furthermore, we asked for the donors’
views on private UCB banking and their opinion on the
drawbacks and assets of public banks. Other topics were
attitudes toward UCB stem cell research in general, best
consent procedure (single-step or two-step procedure) and
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Fig. 1 Number of UCB units delivered per year by SBSC from 1997
to 2007
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the desire to be informed and to re-consent before release
of their donated UCB unit for allogeneic transplantation.
Statistical analysis
The results were assessed as descriptive statistics. Calcu-
lations were performed using a statistical software (SPSS,
Version 14.0, SPSS Inc., Chicago, IL, USA).
Results
Questionnaire and sociodemographic factors
From the 621 questionnaires, 300 were filled out and
returned (48.3%). Of the 621 questionnaires, 98 could not
be successfully delivered due to unknown postal address
(15.8%). The remaining questionnaires (35.9%) were
unanswered and no further information could be obtained
to characterize this group of donors. The maximum interval
between UCB donation and mailing of the questionnaires
was 35 months (median 18, range ±10.01).
The answered questionnaires were mostly from Swiss
donors (56%); 85 were from western European (28.3%)
and 36 from eastern European donors (12%). Nine donors
stated that they came from a country different from the
above-mentioned ones (3%).
Missing data within the questionnaires were rare, rang-
ing from 0.3 to 3.8% for the directed questions. As much as
84% of the open questions remained unanswered.
Sources of information on UCB donation
and its importance during pregnancy
In most cases, information on UCB donation was provided
by the medical health-care professionals (53.8%). This was
either the primary care obstetrician (22.2%) or the obste-
trician in charge of the delivery unit (31.6%). As much as
22% of the women stated that they had more than one
source of information, including family, friends and the
media. During the antenatal visit or at admission to
delivery, 34% actively asked for the option of cord blood
donation. The remaining 66% were informed of the pos-
sibility of UCB donation by their caregiver.
Public versus private banking
Most of the former UCB donors (94.9%) would again
choose to donate UCB to the public bank in their next
pregnancy, while 2.4% would then favor private banking.
The remaining 0.6% would not donate again and 2.1%
were indifferent.
Approximately, 69% of the UCB donors had heard
about private banking as a possible option for their UCB to
be stored, whereas 27% of women stated that they did not
know anything about private UCB banking. One-third of
the UCB donors (34.7%) were primarily convinced about
the advantages of the public banks, whereas 34% discussed
the different options with their family and caregivers and
finally chose donating to the public bank. Reasons for
donating to the public UCB bank were mostly the high
costs of private banking combined with the altruistic
motive of being able to help people in need through the
storage of the UCB unit in the public inventory (69.4%).
Another 16.9% also mentioned organizational reasons, i.e.,
there was not enough time to organize private banking or
they had been informed too late or had never discussed this
topic during pregnancy. Sixteen percent of women gave
detailed information on their particular concerns regarding
public UCB banking (Table 1).
Information and option for re-consent before release
for allogeneic transplantation
A minority of our UCB donors (34.9%) stated that infor-
mation before release of the donated UCB unit for allo-
geneic transplantation was either not necessary or not
important to them. However, 65.1% would appreciate to be
informed about this issue. Most of them (80.9%), although
wishing to be informed, would not opt for re-consent
before releasing the sample. Only 19.1% stated that they
would like to have the option for consenting a second time
(Fig. 2).
Use of rejected UCB units for stem cell research
There were notable differences in our study population of
UCB donors regarding attitudes toward UCB stem cell
research (Fig. 3). The majority (53.5%) would donate a
rejected UCB sample if the particular research project were
known and would therefore opt for a two-step consent
procedure. In this group, 12.3% stated that they were
concerned about unauthorized use of the UCB sample.
Table 1 Concerns about public UCB banking
‘‘Private’’ access for a sick child or family member is not
possible later
36.7%
No chance to decide again later whether or not to release the
UCB for allogeneic transplantation
28.6%
No disadvantages seen at all 24.5%
Complex, time-consuming process (i.e., a lot of paper work) 4.1%
The actual use of the UCB unit is unknown to the donor 4.1%
Concern about unauthorized use for research 2%
This open question was answered on 48 of 300 questionnaires
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About one-third of the UCB donors (37%) would release
their rejected UCB sample in any case for research. In this
group, 65.4% would prefer a single-step consent procedure
including both general informed consent on public UCB
banking plus release for research in case of sample rejec-
tion. Improper use of the UCB sample in research was less
of a concern in this group and was mentioned in only 3.7%
of questionnaires. A third group of women (9% of UCB
donors) indicated that they would never consent for UCB
research. In this group, half would prefer a two-step con-
sent procedure for this reason. Improper use of the UCB
sample in research was an issue for 26.9% of donors in this
group.
Discussion
Public UCB banking for allogeneic stem cell transplantation
has become a well-established alternative therapeutic option
for quickly providing an HLA-typed, immunologically
naı¨ve graft of high proliferative capacity. Since there is
extensive evidence showing that UCB-derived transplants
are at least of similar efficacy as those obtained from adult
peripheral blood or bone marrow even in adults, the need for
UCB banking has been on the rise [9]. In contrast, autolo-
gous UCB stem cell transplantation with UCB banked in
private institutions is currently the exception [10]. Although
autologous UCB banking is of more speculative nature
primarily concerning possible future application in tissue
regeneration, this market is currently growing, whereas
allogeneic public UCB banks worldwide struggle for public
funding. In this context, a combination of private and public
UCB banking would be ideal if quality and safety standards
were equal. The quality of UCB units from private banks,
however, is not well studied and one recent publication on
this topic showed that all quality parameters (volume, CD
34 count, TNC count) were substantially inferior in the UCB
units from the private bank compared to UCB from the
public bank [11].
Additionally, little is known whether such a combina-
tion at all would be an option for the current public UCB
donors.
Informing expectant parents of the possibility of UCB
banking is increasingly becoming a part of routine preg-
nancy visits. Information on this topic needs to be balanced
and accurate, and provide sufficient information on both
the advantages and disadvantages of the two currently
different storage options [12]. This is a challenging task,
especially if cord blood banking is discussed shortly before
birth or even after the due date. Additionally, there is a
growing need for stem cells for research purposes [13]. In
our study, most donors received information during preg-
nancy, mostly from a health-care professional. Although
the media, family and friends do play a role since public
interest in UCB donation is growing, the fact that health-
care professionals addressed the UCB donation in 60% of
the cases shows how important the role of the obstetrician
or primary caregiver is. This is supported by other studies,
which show that doctors need to address the topic and need
to guide the expectant couple in the decision-making pro-
cess to ensure the receipt of balanced and good quality
information [14, 15]. Based on our data, public UCB banks
would miss more than half of their donors if couples were
not actively asked for UCB donation by the physician.
As far as the options of autologous versus allogeneic
UCB donation is concerned, private banking is not popular
among our public banking donors. More than 90% of the
former public UCB donors would choose public banking in
their next pregnancy. The donors realize the current
financial barriers of private banking and acknowledge the
public good of allogeneic UCB banking. We therefore
speculate that combining public and private banking into a
hybrid banking model requiring some personal financial
not necessary not important good option
Fig. 2 The importance of a re-consent before final release of the
UCB sample for allogeneic transplantation
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investment would rather lead to fewer UCB donors from
the population, considering that a third of them are of
immigrant background with most probably limited finan-
cial resources [4].
About one-third of donors stated that they had never
heard of private banking. This might be those who were
admitted to our unit very soon before delivery when
obstetrical care had priority and the two options could not
be discussed in any detail. It is not clear whether in this
situation it would be feasible to explain all issues on hybrid
UCB banking in order for the expectant parents to make an
informed decision.
Donors stated that they would appreciate information if
their donated UCB unit was released for transplantation for
personal reasons, but would prefer not to interfere in this
process through a re-consent. Two-thirds of the donors
stated that the motivation to donate UCB would not be
improved had there been an option to decide on the release
of the UCB for transplantation at a later time. Practically, it
seems to be difficult to contact a relevant proportion of the
public donors for follow-up, even after a relatively short
time period, due to migration. It is therefore difficult to
imagine that a sequential hybrid banking model would
work in our area. This also brings up one major disad-
vantage of this model, which is the increased delay
between transplant request and actual transplantation,
should it be necessary to find former UCB donors for a re-
consent. The other model of hybrid UCB banking is split
hybrid banking. Here, 20% of the UCB volume is stored in
a private bank and 80% of the volume is donated to a
public bank. Although a re-consent is not necessary in this
type of banking, there is another major problem: the TNC
count of each individual UCB unit for the public bank is
reduced by approximately 20%. Since a low TNC count is
one of the most relevant problems in cord blood trans-
plantation in general, the split model is less likely to have
success from a medical point of view. So far, the only cord
blood bank providing this concept is the Virgin Health
Bank in the UK and the results from their bank have not yet
been published.
Over 90% of the public donors accept and support stem
cell research. In case of sample rejection for clinical use,
most of the donors would agree to release their unit for
research experiments. However, only 30% would accept a
general consent at the time of UCB donation. More than
half of the donors wanted to know the exact study and field
of research. Based on our data, a single-step consent pro-
cedure for both UCB donation to the public bank and
research cannot be supported. It remains difficult to find an
optimal way to recruit sufficient donors for research. As
much as 57% of the rejected UCB units could be used for a
particular research project. Since our current two-step
consent procedure is time-consuming, in most of the cases
the sample finally is older then 24 h at the time of consent
and therefore is also no longer suitable for research (data
not shown). Although the general consent would reduce the
administrative costs and make the UCB units available for
research more rapidly, it might be unethical. As an alter-
native, one could primarily offer UCB donation for
research instead of donation to the UCB bank in cases
where the banking rates are known to be low, for example,
in elective cesarean sections [16].
One of the major limitations of our study was that only
donors whose UCB units were finally stored were included.
This design was chosen because we specifically wanted to
study the attitudes, toward hybrid banking, of those who
had previously been involved in UCB donation. It would
be, however, worthwhile to study these attitudes in an
unselected population of pregnant women.
In conclusion, public banking donors appear to be a
well-informed group of people who take an interest in UCB
banking and support research in case of rejection from the
public UCB bank. Although the rights to the UCB unit are
transferred to the UCB bank upon donation, the parents
would appreciate information on release for transplanta-
tion, as well as on release for research purposes in case of
clinical sample rejection. For practical reasons, a split
hybrid banking model would be most feasible when con-
sidering implementation of hybrid banking. However, the
motivation in favor of private banking is low. We conclude
from our results that hybrid banking would not be well
supported by the current UCB donors. It can even be
speculated that the introduction of such a model as the only
type of UCB banking might lead to the loss of a relevant
proportion of the target group of mostly immigrant donors
from ethnic minorities with rare HLA alleles, since the
personal financial contribution would probably act as a
determent to donation.
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